Clinical Trials Directory

Trials / Unknown

UnknownNCT04998630

Comparison of Focused ESWT by Frequency for Patients With Myofascial Pain Syndrome

Comparison of Focused ESWT by Low and High Frequency for Patients With Myofascial Pain Syndrome: a Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
CHA University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

To investigate the efficacy and safety according to the frequency of focused ESWT in patients with myofascial pain syndrome.

Detailed description

Myofascial pain syndrome is one of the common causes of musculoskeletal pain seen in clinical practice and is characterized by the presence of trigger points associated with sensitive areas such as taut bands of skeletal muscle. It may also be accompanied by referred pain, which is pain in other parts of the body. Although the pathophysiology and etiology of myofascial pain syndrome and trigger points are still unknown, there are reports that myofascial pain is a complex form of neuromuscular dysfunction caused by motor and sensory abnormalities involving both the peripheral nervous system and the central nervous system. Recently, it has been considered as a method of treatment for myofascial pain syndrome. In addition, although pain reduction and functional improvement of focused ESWT in patients with myofascial pain syndrome have been reported, related studies are lacking on the effect of focused ESWT according to the frequency difference. The purpose of the study is to examine the efficacy and safety of focused type ESWT frequency in patients with myofascial pain syndrome.

Conditions

Interventions

TypeNameDescription
DEVICEExtracorporeal shockwave therapyTreatment Location: Painful Area Treatment intensity: 2000 pulses, low energy (0.08\~0.28 mJ/m2) the degree to which the subject can tolerate

Timeline

Start date
2021-06-22
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2021-08-10
Last updated
2021-08-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04998630. Inclusion in this directory is not an endorsement.